JOINT HYPERMOBILITY SYNDROME AND ITS CLINICAL SIGNIFICANCE
Article Sidebar
Main Article Content
Abstract
Joint Hypermobility Syndrome (JHS) is a connective tissue disorder characterized by excessive flexibility of the joints beyond the normal range of motion, often accompanied by musculoskeletal pain and instability. This condition predominantly affects children, adolescents, and young adults, and may be associated with recurrent joint dislocations, soft tissue injuries, and functional limitations [1, 2]. Clinical manifestations include joint pain, fatigue, proprioceptive difficulties, and increased risk of sprains or injuries during physical activity. Recent research indicates that JHS may involve both genetic and environmental factors, affecting connective tissue integrity and collagen structure [3, 4]. Early recognition, proper assessment, and individualized management—including physiotherapy, exercise programs, and pain management—are crucial for improving quality of life and preventing long-term complications [5, 6].
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
How to Cite
References
1.Castori, M., Tinkle, B., Levy, H., et al. (2017). A framework for the classification of joint hypermobility and related disorders. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 175(1), 148–157.
2.Hakim, A.J., Grahame, R. (2003). Joint hypermobility. Best Practice & Research Clinical Rheumatology, 17(6), 989–1004.
3.Rombaut, L., Malfait, F., De Wandele, I., et al. (2011). Musculoskeletal complaints, physical activity, and health-related quality of life in the hypermobility syndrome. Rheumatology International, 31(8), 1153–1160.
4.Remvig, L., Jensen, D.V., Ward, R.C. (2007). Epidemiology of generalized joint hypermobility and basis for the proposed criteria. American Journal of Medical Genetics Part A, 143A(1), 14–20.
5.Smith, T.O., Easton, V., Bacon, H., et al. (2014). The relationship between benign joint hypermobility syndrome and musculoskeletal pain in children: a systematic review and meta-analysis. Rheumatology International, 34(4), 519–528.
6.Deane, K.D., Tuttle, J.M., et al. (2018). Clinical features and functional limitations of patients with hypermobility disorders. Clinical Rheumatology, 37(8), 2083–2090.
7.Castori, M., Camerota, F., et al. (2012). Management of musculoskeletal pain in joint hypermobility syndrome. Current Pain and Headache Reports, 16(2), 159–168.
8.Scheper, M.C., Juul-Kristensen, B., et al. (2015). Physiotherapy management of hypermobility-related disorders: a systematic review. Rheumatology International, 35(9), 1445–1455.
9.Tinkle, B.T., Levy, H., et al. (2012). The spectrum of joint hypermobility and related disorders: implications for diagnosis and management. Current Opinion in Pediatrics, 24(6), 653–659.
10.Rombaut, L., Malfait, F., et al. (2010). Pain, fatigue, and functional disability in joint hypermobility syndrome: a patient-centered perspective. Seminars in Arthritis and Rheumatism, 40(4), 267–275.